In continuation of my update on Dutasteride (Avodaart)
New research suggests that Avodart, a drug used to treat an enlarged prostate gland, may help slow the progression of early stage prostate cancer, reducing the need for aggressive treatment in some men.
Avodart belongs to a class of drugs called 5-alpha reductase inhibitors.
These drugs work by interfering with the effects of certain male
hormones on the prostate. In the three-year study, prostate cancer
progressed in 38 percent of 144 men with early prostate cancer who were
treated with Avodart and 48 percent of the 145 men who received a
placebo....
More...
